Skip to content

Annotations for the PI-CAI Challenge: Public Training and Development Dataset

License

Notifications You must be signed in to change notification settings

DIAGNijmegen/picai_labels

Repository files navigation

Annotations for the PI-CAI Challenge: Public Training and Development Dataset

Imaging Dataset

To download the associated imaging data, visit: https://zenodo.org/record/6624726. Note, the Public Training and Development Dataset of the PI-CAI challenge includes 328 cases from the ProstateX challenge. Thus, we strongly recommend using this dataset exclusively, and not in addition to the ProstateX dataset.

Reference Standard for Annotations

Patient cases used for the training datasets of the PI-CAI challenge were annotated with the same reference standard as used for the ProstateX challenge, i.e. histologically-confirmed (ISUP ≥ 2) positives, and histologically- (ISUP ≤ 1) or MRI- (PI-RADS ≤ 2) confirmed negatives, without follow-up. Note, this means that certain patients (e.g. 11054) can have a prior study that was found to be negative (1001074 in 2018), but a subsequent study that was found to be positive (1001075 in 2020). In this case, each study was annotated with respect to its associated histopathology or radiology findings only. From our institutional findings at RUMC (Venderink et al., 2019), such scenarios typically emerge for less than <1% negative cases.

Annotations and Resources

For all cases, csPCa lesions were delineated and/or csPCa outcomes were recorded, by one of 10 trained investigators or 1 radiology resident, under supervision of one of 3 expert radiologists, at RUMC or UMCG. Lesion delineations were created using ITK-SNAP v3.80.

Out of the 1500 cases shared in the Public Training and Development Dataset, 1075 cases have benign tissue or indolent PCa (i.e. their labels should be empty or full of 0s) and 425 cases have csPCa (i.e. their labels should have lesion blobs of value 2, 3, 4 or 5). Out of these 425 positive cases, only 220 cases carry an annotation derived by a human expert. Remaining 205 positive cases have not been annotated. In other words, only 17% (220/1295) of the annotations provided in picai_labels/csPCa_lesion_delineations/human_expert should have csPCa lesion annotations, while the remaining 83% (1075/1295) of annotations should be empty.

Automated AI-derived delineations of the prostate whole-gland (see algorithm used for this task) and csPCa lesions (Bosma et al., 2022) have also been made available.

Location Description
csPCa_lesion_delineations/
human_expert/original/
Original csPCa annotations, as made by one of the trained investigators or radiology resident. Depending on the annotator/center and their preference, some of these annotations were mapped or created at the spatial resolution of the T2W image, while others have been created at the resolution of the ADC or DWI/HBV images. Either way, for every annotation in this folder, all lesion delineations will always clearly map to observations in DWI/ADC imaging. Available for 1295/1500 (86%) cases.
csPCa_lesion_delineations/
human_expert/resampled/
Original csPCa annotations resampled to the spatial resolution of the associated axial T2-weighted scan. Available for 1295/1500 (86%) cases.
csPCa_lesion_delineations/
AI/Bosma22a
Automated AI-derived delineations of csPCa lesions (Bosma et al., 2022a).
anatomical_delineations/
whole_gland/AI/Bosma22b
Automated AI-derived delineations of the prostate whole-gland (see algorithm used for this task). Note, that AI-derived annotations can be susceptible to errors or faulty segmentations (e.g. whole-gland segmentation for case 11050_1001070).
clinical_information/
marksheet.csv/
Clinical information (patient age, PSA, PSA density, prostate volume) and overview of each study (e.g. anonymized study date, MRI vendor and scanner used for acquisition, GS per lesion {if prostatectomy or biopsies were performed}) in this dataset.

Label Mapping of csPCa Annotations

All expert-derived csPCa annotations carry granular or multi-class labels (ISUP ≤ 1, 2, 3, 4, 5), while all automated AI-derived annotations carry binary labels (ISUP ≤ 1 or ≥ 2).

Label Expert-Derived Annotations AI-Derived Annotations
0 ISUP ≤ 1 ISUP ≤ 1
1 N/A ISUP ≥ 2
2 ISUP 2 N/A
3 ISUP 3 N/A
4 ISUP 4 N/A
5 ISUP 5 N/A

List of Clinical Information Descriptors

Descriptor Meaning
patient_id Anonymized patient ID.
study_id Anonymized study ID. Multiple study IDs can be assigned to the same patient ID.
mri_date Anonymized date at the time of the MRI study.
patient_age Patient age at the time of the MRI study.
psa Prostate-specific antigen level (PSA) (unit: ng/mL), as stated in the radiology report associated with the MRI study. If this value is missing, then it was not reported for the given study.
prostate_volume Prostate volume (unit: mL), as stated in the radiology report associated with the MRI study. In clinical practice, this value is typically approximated using the conventional prolate ellipsoid model. If this value is missing, then it was not reported for the given study.
psad Prostate-specific antigen density (PSAd) (unit: ng/mL²), as stated in the radiology report associated with the MRI study. Note, this value may not neccessarily be the same as the PSA divided by the prostate volume, due to approximations and rounding errors during clinical reporting. If this value is missing, then it was not reported for the given study.
histopath_type Procedure used to sample lesion tissue specimen for microscopic or histopathologic analysis. Its value can be SysBx for systematic biopsies, MRBx for MR-guided biopsies, SysBx+MRBx for systematic and MR-guided biopsies, or RP for radical prostatectomy. If its value is missing, then no tissue sampling procedure was performed; indicating a negative MRI study.
lesion_GS Gleason score (GS) assigned to each lesion after histopathologic analysis, where scores for different lesions are separated by , (commas). If its value is missing, then no tissue sampling procedure was performed; indicating a negative MRI study. If its value is N/A only for specific lesion(s), then those lesion(s) (as observed in radiology) were not biopsied or graded in histopathology (typically the case for PI-RADS 1-2 lesions).
center Site ID for the tertiary care center where the patient examination had been acquired, with the following keys: RUMC: Radboud University Medical Center, Nijmegen; ZGT: Ziekenhuisgroep Twente, Hengelo; PCNN: Prostaat Centrum Noord-Nederland, Groningen.

Dataset Characteristics

Characteristic Frequency
Number of sites 11
Number of MRI scanners 5 S, 2 P
Number of patients 1476
Number of cases 1500
— Benign or indolent PCa 1075
— csPCa (ISUP ≥ 2) 425
Median age (years) 66 (IQR: 61–70)
Median PSA (ng/mL) 8.5 (IQR: 6–13)
Median prostate volume (mL) 57 (IQR: 40–80)
Number of positive MRI lesions 1087
— PI-RADS 3 246 (23%)
— PI-RADS 4 438 (40%)
— PI-RADS 5 403 (37%)
Number of ISUP-based lesions 776
— ISUP 1 311 (40%)
— ISUP 2 260 (34%)
— ISUP 3 109 (14%)
— ISUP 4 41 (5%)
— ISUP 5 55 (7%)

Open-Source Contributions

We encourage open-source contributions! For instance, you can contribute expert-derived delineations of the prostate whole-gland and zonal anatomy at the spatial resolution of axial T2-weighted images. If you're interested, feel free to propose PRs for inclusion to this repo. Pending quality control, substantial contributions will be merged in and credited accordingly.

Reference

If you are using this codebase or some part of it, please cite the following article:

Saha A, Bosma JS, Twilt JJ, et al. Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study. Lancet Oncol 2024; 25: 879–887

BibTeX:

@ARTICLE{SahaBosmaTwilt2024,
  title = {Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study},
  journal = {The Lancet Oncology},
  year = {2024},
  issn = {1470-2045},
  volume={25},
  number={7},
  pages={879--887},
  doi = {https://doi.org/10.1016/S1470-2045(24)00220-1},
  author = {Anindo Saha and Joeran S Bosma and Jasper J Twilt and Bram {van Ginneken} and Anders Bjartell and Anwar R Padhani and David Bonekamp and Geert Villeirs and Georg Salomon and Gianluca Giannarini and Jayashree Kalpathy-Cramer and Jelle Barentsz and Klaus H Maier-Hein and Mirabela Rusu and Olivier Rouvière and Roderick {van den Bergh} and Valeria Panebianco and Veeru Kasivisvanathan and Nancy A Obuchowski and Derya Yakar and Mattijs Elschot and Jeroen Veltman and Jurgen J Fütterer and Constant R. Noordman and Ivan Slootweg and Christian Roest and Stefan J. Fransen and Mohammed R.S. Sunoqrot and Tone F. Bathen and Dennis Rouw and Jos Immerzeel and Jeroen Geerdink and Chris {van Run} and Miriam Groeneveld and James Meakin and Ahmet Karagöz and Alexandre Bône and Alexandre Routier and Arnaud Marcoux and Clément Abi-Nader and Cynthia Xinran Li and Dagan Feng and Deniz Alis and Ercan Karaarslan and Euijoon Ahn and François Nicolas and Geoffrey A. Sonn and Indrani Bhattacharya and Jinman Kim and Jun Shi and Hassan Jahanandish and Hong An and Hongyu Kan and Ilkay Oksuz and Liang Qiao and Marc-Michel Rohé and Mert Yergin and Mohamed Khadra and Mustafa E. Şeker and Mustafa S. Kartal and Noëlie Debs and Richard E. Fan and Sara Saunders and Simon J.C. Soerensen and Stefania Moroianu and Sulaiman Vesal and Yuan Yuan and Afsoun Malakoti-Fard and Agnė Mačiūnien and Akira Kawashima and Ana M.M. de M.G. {de Sousa Machadov} and Ana Sofia L. Moreira and Andrea Ponsiglione and Annelies Rappaport and Arnaldo Stanzione and Arturas Ciuvasovas and Baris Turkbey and Bart {de Keyzer} and Bodil G. Pedersen and Bram Eijlers and Christine Chen and Ciabattoni Riccardo and Deniz Alis and Ewout F.W. {Courrech Staal} and Fredrik Jäderling and Fredrik Langkilde and Giacomo Aringhieri and Giorgio Brembilla and Hannah Son and Hans Vanderlelij and Henricus P.J. Raat and Ingrida Pikūnienė and Iva Macova and Ivo Schoots and Iztok Caglic and Jeries P. Zawaideh and Jonas Wallström and Leonardo K. Bittencourt and Misbah Khurram and Moon H. Choi and Naoki Takahashi and Nelly Tan and Paolo N. Franco and Patricia A. Gutierrez and Per Erik Thimansson and Pieter Hanus and Philippe Puech and Philipp R. Rau and Pieter {de Visschere} and Ramette Guillaume and Renato Cuocolo and Ricardo O. Falcão and Rogier S.A. {van Stiphout} and Rossano Girometti and Ruta Briediene and Rūta Grigienė and Samuel Gitau and Samuel Withey and Sangeet Ghai and Tobias Penzkofer and Tristan Barrett and Varaha S. Tammisetti and Vibeke B. Løgager and Vladimír Černý and Wulphert Venderink and Yan M. Law and Young J. Lee and Maarten {de Rooij} and Henkjan Huisman},
}

License

CC BY-NC 4.0

Managed By

Diagnostic Image Analysis Group, Radboud University Medical Center, Nijmegen, The Netherlands

Contact Information